Biological reactive intermediates in drug discovery and development - A perspective from the pharmaceutical industry

被引：0

作者：

Baillie, TA ^{[1
]}

Kassahun, K ^{[1
]}

机构：

[1] Merck Res Labs, Dept Drug Metab, W Point, PA 19486 USA

来源：

BIOLOGICAL REACTIVE INTERMEDIATES VI: CHEMICAL AND BIOLOGICAL MECHANISMS IN SUSCEPTIBILITY TO AND PREVENTION OF ENVIRONMENTAL DISEASES | 2001年 / 500卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：45 / 51

页数：7

共 9 条

[1] MASS-SPECTROMETRY IN THE ANALYSIS OF GLUTATHIONE CONJUGATES [J].

BAILLIE, TA ;

DAVIS, MR .

[2]

DEMONTELLANO PRO, 1975, CYTOCHROME P450 STRU, P245

[3]

KASSAHUN K, 2000, UNPUB STUDIES METABO

[4]

Kohlroser J, 2000, AM J GASTROENTEROL, V95, P272

[5]

NELSON SD, 1990, ANNU REV PHARMACOL, V30, P169

PEARSON, PG ;

THREADGILL, MD ;

HOWALD, WN ;

BAILLIE, TA .

BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, 1988, 16 (1-12) :51-56

[7] Protein targets of xenobiotic reactive intermediates [J].

Pumford, NR ;

Halmes, NC .

[8]

THOMASSEN D, 1990, FASEB Journal, V4, pA599

Uetrecht, JP .